The FDA is removing any mention of risks related to breast cancer, heart disease, and dementia on hormone therapy products ...
New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel antibiotic candidate sorfequiline (TBAJ-876), a next-generation diarylquinoline, ...
Sorfequiline, previously known as TBAJ-876, was evaluated in combination with pretomanid and linezolid in a randomized, controlled trial in people with drug-sensitive TB COPENHAGEN (November 19, 2025) ...
Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...
News-Medical.Net on MSN
New clinical trial shows promise for shorter TB treatment
New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...
Researchers in the TB Alliance informed the Union Conference on Lung Health in Copenhagen that Sorbequiline, a new antibiotic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback